Sunshine Biopharma, Inc. (SBFM)
1.05
-0.03
(-2.78%)
USD |
NASDAQ |
May 07, 16:00
1.05
0.00 (0.00%)
After-Hours: 18:35
Sunshine Biopharma Profit Margin (Quarterly) : -24.96% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | 13.55% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -25.08% |
| Return on Assets | -19.49% |
| Return on Invested Capital | -24.17% |
| Gross Profit Margin (Quarterly) | 34.16% |
| Operating Margin (Quarterly) | -19.33% |
| Return on Net Operating Assets | -28.11% |